期刊文献+

儿童急性B淋巴细胞白血病的分子特征及临床意义

Molecular Characteristics and Clinical Significance of Acute B-Cell Acute Lymphoblastic Leukemia in Children
下载PDF
导出
摘要 儿童急性淋巴细胞白血病是儿童时期最常见的血液恶性肿瘤,虽然病因研究已进行多年,但其在遗传水平上仍是一种异质性疾病。近年来随着测序技术的进步,遗传特征得到更深入的阐述。本文即从儿童急性B淋巴细胞白血病的常见分子特征进行简要概述,并讨论了它们对临床的影响。 Acute lymphoblastic leukemia is the most common hematologic malignancy in children. Although the etiology has been studied for a long time, it is still a heterogeneous disease at the genetic level. While with the development of sequencing technology in recent years, genetic characteristics have been further elaborated. In this article, the common molecular characteristics of acute B-cell lym-phoblastic leukemia in children are briefly summarized, and their clinical effects are discussed.
作者 李钰
出处 《临床医学进展》 2023年第4期6469-6477,共9页 Advances in Clinical Medicine
  • 相关文献

参考文献4

二级参考文献34

  • 1Gao C, Zhao XX, Li WJ, et al. Clinical features, early treatment responses, and outcomes of pediatric acute lymphoblastic leukemia in China with or without specific fusion transcripts : a single institutional study of 1,004 patients. Am J I-tematol, 2012 , 87 ( 11 ) : 1022 - 1027.
  • 2Rubnitz JE, Wichlan D, Devidas M, et al. Prospective analysis of TEL gene rearrangements in childhood acute lymphoblastic leukemia : a Children's Oncology Group study. J Clin Oncol,2008 ,26 (13): 2186 -2191.
  • 3Forestier E, Heyman M, Andersen MK, et al. Outcome of ETV6/ RUNX1-positive childhood acute lymphoblastic leukaemia in the NO- PHO-ALL-1992 protocol: frequent late relapses but good overall sur- vival. Br J Haematol,2008 , 140 (6) :665 - 672.
  • 4Bruggemann M, Schrauder A, Raft T, et al. Standardized MRD quantification in European ALL trials : proceedings of the Second In- ternational Symposium on MRD assessment in Kiel, Germany, 18 - 20 September 2008. Leukemia,2010 ,24 (3) :521 - 535.
  • 5van der Velden VH, Cazzaniga G, Schrauder A, et al. Analysis of minimal residual disease by Ig/TCR gene rearrangements: guidelines for interpretation of real-time quantitative PCR data. Leukemia, 2007 ,21 (4) :604 -611.
  • 6van der Velden VH, Panzer-Grumayer ER, Cazzaniga G, et al. Op- timization of PCR-based minimal residual disease diagnostics for childhood acute lymphoblastic leukemia in a multi-center setting. Leukemia,2007 , 21 ( 4 ) :706 - 713.
  • 7Nguyen K, Devidas M, Cheng SC, et al. Factors influencing surviv- al after relapse from acute lymphoblastic leukemia: a Children's On- cology Group study. Leukemia,2008 ,22(12) :2142 - 2150.
  • 8Teachey DT, Hunger SP. Predicting relapse risk in childhood acute lymphoblastic leukaemia. Br J Haematol,2013 ,162(5) :606 -620.
  • 9Eoh ML, Goldwasser MA, Silverman LB, et al. Prospective analysis of TEL/AMLl-positive patients treated on Dana-Farber Cancer Insti- tute Consortium Protocol 95-01. Blood, 2006, 107 ( 11 ) :4508 - 4513.
  • 10Hubeek I, Ramakers-Van Woerden NL, Pieters R, et al. Tel/Amll Fusion is Not a Prognostic Factor in Dutch Childhood Acute Lympho- blastic Leukaemia. Br J Haematol,2001 , 113 ( 1 ) :254 - 258.

共引文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部